Association of Endodontic Infection With Cardiovascular Disease.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03425383 |
|
Recruitment Status : Unknown
Verified September 2017 by Postgraduate Institute of Dental Sciences Rohtak.
Recruitment status was: Recruiting
First Posted : February 7, 2018
Last Update Posted : February 7, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Apical Periodontitis | Diagnostic Test: FMD and c-IMT |
Show detailed description
| Study Type : | Observational |
| Estimated Enrollment : | 120 participants |
| Observational Model: | Other |
| Time Perspective: | Cross-Sectional |
| Official Title: | Association of Endodontic Infection With Cardiovascular Disease Via Non-invasive Assessment of Endothelial Function |
| Actual Study Start Date : | November 1, 2016 |
| Estimated Primary Completion Date : | March 30, 2018 |
| Estimated Study Completion Date : | March 30, 2018 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Test group
Subjects having periapical disease diagnosed clinically and radiographically and free from any other systemic illness. FMD and c-IMT will be determined by ultrasound
|
Diagnostic Test: FMD and c-IMT
The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA). c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position. |
|
Control group
Healthy subject. FMD and c-IMT will be determined by ultrasound
|
Diagnostic Test: FMD and c-IMT
The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA). c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position. |
- Difference in FMD and c-IMT between test and control groups. [ Time Frame: 1 year ]The primary outcome variables observed for the study will be the difference in the FMD and c-IMT of the test group and control group.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Male |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Males between 20-40 years of age |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 20-40 years of Male.
- Presence of apical periodontitis as assessed both clinically and radiographically (teeth with apical symptoms but without radiographic appearance of AP were not include).
- Presence of at least 25 teeth.
- Echocardiographic Left Ventricle Ejection Fraction (LVEF) value >55%.
- Hepatic and renal function within normal limits (bilirubin<1.5mg/dl; creatine<2.0mg/dl).
Exclusion Criteria:
- Presence of localized or diffuse periodontal disease.
- Presence of non-endodontic lesion in Maxilla/ mandible.
- Presence of cardiovascular risk factors(arterial hypertension, dyslipidemia, DM, obesity, smoking)
- LV hypertrophy at echocardiography previous or current CVD.
- Presence of chronic inflammatory conditions in other regions involving systemic health.
- For women, use of anticonceptive hormones.
- Systemic antibiotic treatment within the previous 3 months or any other regular medication.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03425383
| Contact: NISHANT CHAUHAN | 9991772647 | catchnishu619@gmail.com |
| India | |
| Post Graduate Institute of Dental Sciences | Recruiting |
| Rohtak, Haryana, India, 124001 | |
| Contact: Sanjay Tewari 283876 ext 01262 principalpgids@yahoo.in | |
| Responsible Party: | Postgraduate Institute of Dental Sciences Rohtak |
| ClinicalTrials.gov Identifier: | NCT03425383 |
| Other Study ID Numbers: |
Nishant |
| First Posted: | February 7, 2018 Key Record Dates |
| Last Update Posted: | February 7, 2018 |
| Last Verified: | September 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Cardiovascular disease, FMD, c-IMT |
|
Periodontitis Periapical Periodontitis Cardiovascular Diseases Periodontal Diseases |
Mouth Diseases Stomatognathic Diseases Periapical Diseases Jaw Diseases |

